<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> triggers a local and systemic <z:mp ids='MP_0001845'>inflammatory response</z:mp> leading to the production of cytokines that can influence blood vessel reactivity </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we aimed to assess whether <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion could affect vasoconstriction and vasodilatation on mesenteric resistance arteries (MRA) from Wistar Kyoto rats </plain></SENT>
<SENT sid="2" pm="."><plain>The right middle cerebral artery was occluded (90 min) and reperfused (24 h) </plain></SENT>
<SENT sid="3" pm="."><plain>Sham-operated animals were used as controls </plain></SENT>
<SENT sid="4" pm="."><plain>Plasma levels of interleukin (IL)-6 and IL-1beta were measured at 24 h </plain></SENT>
<SENT sid="5" pm="."><plain>Vasoconstrictor and <z:chebi fb="1" ids="35620">vasodilator</z:chebi> responses were recorded in a wire myograph </plain></SENT>
<SENT sid="6" pm="."><plain>Protein expression was determined by Western blot and immunofluorescence, and <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> (<z:chebi fb="0" ids="15379">O(2)</z:chebi>(.)) production was evaluated by <z:chebi fb="0" ids="42478">ethidium</z:chebi> fluorescence </plain></SENT>
<SENT sid="7" pm="."><plain>In MRA, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion increased plasma levels of IL-6, O2. production, protein expression of cyclooxygenase-2, and protein tyrosine nitrosylation, but it impaired <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> (<z:chebi fb="0" ids="15355">ACh</z:chebi>) vasodilatation without modifying the vasodilatations to <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> or the contractions to <z:chebi fb="0" ids="8093">phenylephrine</z:chebi> and <z:chebi fb="0" ids="32588">KCl</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="1" ids="18421">Superoxide</z:chebi> dismutase (SOD) and <z:chebi fb="0" ids="49662">indomethacin</z:chebi> reversed the impairment of <z:chebi fb="0" ids="15355">ACh</z:chebi> relaxation induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="9" pm="."><plain>However, N(omega)-<z:chebi fb="13" ids="29785">nitro</z:chebi>-l-arginine <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> affected similarly <z:chebi fb="0" ids="15355">ACh</z:chebi>-induced vasodilatations in MRA of ischemic and sham-operated rats </plain></SENT>
<SENT sid="10" pm="."><plain>Protein expression of endothelial and inducible nitric-<z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, copper/zinc SOD, <z:chebi fb="70" ids="18291,35154">manganese</z:chebi> SOD, and extracellular SOD was similar in both groups of rats </plain></SENT>
<SENT sid="11" pm="."><plain>Our results show MRA <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> 24 h after <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="12" pm="."><plain>Excessive production of O2. in MRA mediates <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, and the increase in plasma cytokine levels after <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>/reperfusion might be involved in this effect </plain></SENT>
</text></document>